Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer

This publication has 77 references indexed in Scilit:

• Method for evaluating research and guideline evidence
  New South Wales Public Health Bulletin, 1997
• Effects of medroxyprogesterone acetate therapy on advanced or recurrent breast cancer and its influences on blood coagulation and the fibrinolytic system
  Surgery Today, 1995
• Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months
  European Journal Of Cancer, 1993
• Confronting publication bias: A cohort design for meta‐analysis
  Statistics in Medicine, 1987
• A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia.
  Journal of Clinical Oncology, 1986
• A Randomized Trial of Chemotherapy and Hormonal Therapy in Advanced Breast Cancer
  New England Journal of Medicine, 1985
• Treatment of metastatic breast cancer in estrogen receptor positive patients a randomized trial comparing tamoxifen alone versus tamoxifen plus CMF
  Cancer, 1982
• An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy A later analysis
  American Journal of Clinical Oncology, 1982
• Randomized evaluation of combination chemotherapy vs. observation alone following response or stabilization after oophorectomy for metastatic breast cancer in premenopausal women
  American Journal of Clinical Oncology, 1982
• Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy. A study by cancer and leukemia group B
  Cancer, 1979